Researchers Identify New Cost Savings and Accuracy of C2N Diagnostics' Blood Tests to Enable Healthcare Providers to Better Identify Alzheimer's Disease | Business
ST. LOUIS--(BUSINESS WIRE)--Nov 16, 2023--
Source: valdostadailytimes.com
Robert Rissman News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Robert Rissman. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Robert Rissman Today - Breaking & Trending Today
New Research Shows High Accuracy of Precivity™ Blood Biomarkers in the Evaluation of Brain Amyloid i
ST. LOUIS--(BUSINESS WIRE)--#Alzheimers--C2N Diagnostics, LLC (C2N), a leader in advanced brain health diagnostics, announced new findings that its blood biomarkers Aβ42/Aβ40 (amyloid-beta) and p-tau217/np-tau217 (%p-tau217, or phosphorylated tau-217 divided by non-phosphorylated tau-217)1 are helpful in improving t...
Source: pharmiweb.com
Researchers give insights into pathology of new type of dementia, LATE
LATE, also known as limbic predominant age-related TDP-43 encephalopathy, is a recently identified type of dementia that impairs social, cognitive, and memory a
Source: sandiegosun.com
Looking for an early sign of LATE
Limbic predominate age-related TDP-43 encephalopathy or LATE is a recently recognized form of dementia that affects memory, thinking and social skills. It mimics Alzheimer's disease or AD (and sometimes co-exists with it), but LATE is a different condition, with its own risks and causes.
Source: news-medical.net
Keystone Bio Adds Significant Scientific Leadership with Appointment of Medical Advisor and New Scie
Michael Rafii, M.D., Ph.D., joins leadership team as Senior Medical Advisor, NeurologyCompany announces SAB with members’ deep expertise in neurological and cardio-metabolic diseasesST. LOUIS--(BUSINESS WIRE)--Keystone Bio, a clinical-stage biotechnology company working to stop inflammatory-based disease at its sour...
Source: pharmiweb.com